Zidovudine monotherapy in pregnancy: is it state of the art?*

This publication has 10 references indexed in Scilit:

• Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV‐1‐infected women
  HIV Medicine, 2008
• Recommendations for human immunodeficiency virus screening, prophylaxis, and treatment for pregnant women in the United States
  American Journal of Obstetrics and Gynecology, 2007
• Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis
  AIDS, 2007
• Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth
  AIDS, 2006
• Is Antiretroviral Therapy during Pregnancy Associated with an Increased Risk of Preterm Delivery, Low Birth Weight, or Stillbirth?
  The Journal of Infectious Diseases, 2006
• Increased risk of adverse pregnancy outcomes in HIV-infected women treated with highly active antiretroviral therapy in Europe
  AIDS, 2004
• Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission
  AIDS, 2003
• Human Immunodeficiency Virus Rebound after Suppression to <400 Copies/mL during Initial Highly Active Antiretroviral Therapy Regimens, according to Prior Nucleoside Experience and Duration of Suppression
  The Journal of Infectious Diseases, 2002
• Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome
  New England Journal of Medicine, 2002
• A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in Human Immunodeficiency Virus Infection
  The Journal of Infectious Diseases, 2002